section name header

Y-Site Injection Compatibility (1:1 Mixture)

Eravacycline dihydrochloride

(Mfr: TET)(Conc: 0.3 and 0.6 mg/mLa)

I

Meropenem

(Mfr: FRK)(Conc: 20 mg/mLa)

Remarks:

Measured turbidity increased immediately

Ref:

3532